Docoh
Loading...

UPLD Upland Software

News

From Benzinga Pro
Canaccord Genuity Maintains Buy on Upland Software, Lowers Price Target to $48
5 Aug 21
News, Price Target, Analyst Ratings
Canaccord Genuity analyst Richard Davis maintains Upland Software (NASDAQ:UPLD) with a Buy and lowers the price target from $57 to $48.
Raymond James Maintains Outperform on Upland Software, Lowers Price Target to $50
5 Aug 21
News, Price Target, Analyst Ratings
Raymond James analyst Brian Peterson maintains Upland Software (NASDAQ:UPLD) with a Outperform and lowers the price target from $55 to $50.
Upland Software Sees Q3 Sales $75.4M-$79.4M vs $77.5M Est.l Sees FY21 Sales $300.8M-$321.8M vs $307.03M Est.
4 Aug 21
News, Guidance
Business Outlook For the quarter ending September 30, 2021, Upland expects reported total revenue to be between $75.4 and $79.4 million, including subscription and support revenue
Upland Software Q2 EPS $0.41 Misses $0.42 Estimate, Sales $76.30M Beat $75.26M Estimate
4 Aug 21
Earnings, News
Upland Software (NASDAQ:UPLD) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.42 by 2.38 percent. This is a 31.67 percent decrease over earnings of $0.60 per share from
Upland Software Q2 EPS $0.41 Misses $0.42 Estimate, Sales $76.30M Beat $75.26M Estimate
4 Aug 21
Earnings, News
Upland Software (NASDAQ:UPLD) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.42 by 2.38 percent. This is a 31.67 percent decrease over earnings of $0.60 per share from
Unusual Options Activity Insight: Upland Software
4 Aug 21
Movers
Upland Software (NASDAQ:UPLD) shares experienced unusual options activity on Wednesday. The stock price moved down to $34.76 following the option alert.
Earnings Scheduled For August 4, 2021
4 Aug 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.